Biomarin Pharmaceutical (BMRN) Prepaid Assets (2009 - 2026)

Biomarin Pharmaceutical has disclosed Prepaid Assets across 18 years of filings, most recently posting $205.5 million for Q1 2026.

• Quarterly Prepaid Assets rose 13.2% year-over-year to $205.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $205.5 million (up 13.2% YoY) and the FY2025 annual result came in at $185.8 million, down 7.81% from the prior year.
• Prepaid Assets improved to $205.5 million in Q1 2026, from $185.8 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $224.8 million in Q3 2023 and troughed at $104.5 million in Q4 2022.
• A 5-year average of $170.4 million and a median of $173.2 million in 2023 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2023 — Prepaid Assets surged 50.02% — and 2024, when it fell 24.71%.
• Tracing BMRN's Prepaid Assets over 5 years: stood at $104.5 million in 2022, then soared by 35.28% to $141.4 million in 2023, then soared by 42.54% to $201.5 million in 2024, then declined by 7.81% to $185.8 million in 2025, then climbed by 10.61% to $205.5 million in 2026.
• Business Quant data shows BMRN's Prepaid Assets at $205.5 million in Q1 2026, $185.8 million in Q4 2025, and $204.3 million in Q3 2025.